4-(Bromomethyl)phenylboronic acid

We are 4-(Bromomethyl)phenylboronic acid CAS:68162-47-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 4-(Bromomethyl)phenylboronic acid
Other Name:
4-(Bromomethyl)phenylboronic acid
[4-(bromomethyl)phenyl]boronic acid
CAS No: 68162-47-0
MF: C7H8BBrO2
MW: 214.85200
Density: 1.57 g/cm3
Boiling point: 343.1ºC at 760 mmHg
Melting point: 78-81°C
Flash point: 161.3ºC
Refractive index: 1.582
UN Number: Non-dangerous goods
Transport hazard class: Non-dangerous goods
Packing group: Non-dangerous goods
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-(Bromomethyl)phenylboronic acid


Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.1,3-difluoro-5-nitrobenzene CAS:2265-94-3 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.5- (trifluorometil) picolinonitrilo CAS:95727-86-9 Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.127-47-9 International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.

Related Products
Product Name
Ozarelix Acetate View Details
6-Fluoroindole-2-carboxylic acid View Details
2-Amino-6-methylheptane hydrochloride View Details
2-Chlorobenzaldehyde manufacturer N-ETHYLFORMAMIDE manufacturer N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane sulfonamide manufacturer 1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone manufacturer methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate manufacturer